CSTL
insider transactionsCASTLE BIOSCIENCES INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-20.9K
0 buy · 20.9K sell
Net value · 30d
-$434.6K
$0 in · $434.6K out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
9
0 buy · 20.9K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Chief Operating Officer · 10b5-1
$177.8K
8.6K sh · $20.71
Own -22%
-
Exercise·M
Derek J Maetzold KEY
Pres. & Chief Exec. Officer · 10b5-1
$0
550 sh
Own +1%
-
Sell·S
Derek J Maetzold KEY
Pres. & Chief Exec. Officer · 10b5-1
$5.7K
278 sh · $20.66
Own -2%
-
Sell·S
Derek J Maetzold KEY
Pres. & Chief Exec. Officer · 10b5-1
$23.8K
1.2K sh · $20.66
Own -3%
-
Sell·S
Derek J Maetzold KEY
Pres. & Chief Exec. Officer · 10b5-1
$28.0K
1.4K sh · $20.66
Own -3%
-
Sell·S
Derek J Maetzold KEY
Pres. & Chief Exec. Officer · 10b5-1
$11.4K
550 sh · $20.66
Own -2%
-
Exercise·M
Derek J Maetzold KEY
Pres. & Chief Exec. Officer · 10b5-1
$1.3K
550 sh · $2.39
Own +3%
-
Exercise·M
Derek J Maetzold KEY
Pres. & Chief Exec. Officer · 10b5-1
$0
6.0K sh
Own +7%
-
Exercise·M
Derek J Maetzold KEY
Pres. & Chief Exec. Officer · 10b5-1
$0
204 sh
Own New
-
Sell·S
Derek J Maetzold KEY
Pres. & Chief Exec. Officer · 10b5-1
$5.8K
278 sh · $20.86
Own -14%
-
Sell·S
Derek J Maetzold KEY
Pres. & Chief Exec. Officer · 10b5-1
$24.0K
1.2K sh · $20.86
Own -3%
-
Sell·S
Derek J Maetzold KEY
Pres. & Chief Exec. Officer · 10b5-1
$28.3K
1.4K sh · $20.86
Own -3%
-
Sell·S
Derek J Maetzold KEY
Pres. & Chief Exec. Officer · 10b5-1
$129.6K
6.2K sh · $20.86
Own -22%
-
Exercise·M
Derek J Maetzold KEY
Pres. & Chief Exec. Officer · 10b5-1
$14.4K
6.0K sh · $2.39
Own +28%
-
Exercise·M
Derek J Maetzold KEY
Pres. & Chief Exec. Officer · 10b5-1
$488
204 sh · $2.39
Own +1%
-
Grant·A
Director
$0
11.8K sh
Own New
-
Grant·A
Director
$0
11.8K sh
Own New
-
Grant·A
Director
$0
11.8K sh
Own New
-
Grant·A
Director
$0
11.8K sh
Own New
-
Grant·A
Director
$0
11.8K sh
Own New
-
Grant·A
Director
$0
11.8K sh
Own New
-
Grant·A
Director
$0
11.8K sh
Own New
-
Grant·A
Daniel Bradbury KEY
CHAIRMAN
$0
70.0K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Kristen M Oelschlager 10b5-1 | Sell S | 8.6K | $177.8K |
| Jun 15, 2026 | Derek J Maetzold KEY 10b5-1 | Exercise M | 550 | $0 |
| Jun 15, 2026 | Derek J Maetzold KEY 10b5-1 | Sell S | 278 | $5.7K |
| Jun 15, 2026 | Derek J Maetzold KEY 10b5-1 | Sell S | 1.2K | $23.8K |
| Jun 15, 2026 | Derek J Maetzold KEY 10b5-1 | Sell S | 1.4K | $28.0K |
| Jun 15, 2026 | Derek J Maetzold KEY 10b5-1 | Sell S | 550 | $11.4K |
| Jun 15, 2026 | Derek J Maetzold KEY 10b5-1 | Exercise M | 550 | $1.3K |
| Jun 1, 2026 | Derek J Maetzold KEY 10b5-1 | Exercise M | 6.0K | $0 |
| Jun 1, 2026 | Derek J Maetzold KEY 10b5-1 | Exercise M | 204 | $0 |
| Jun 1, 2026 | Derek J Maetzold KEY 10b5-1 | Sell S | 278 | $5.8K |
| Jun 1, 2026 | Derek J Maetzold KEY 10b5-1 | Sell S | 1.2K | $24.0K |
| Jun 1, 2026 | Derek J Maetzold KEY 10b5-1 | Sell S | 1.4K | $28.3K |
| Jun 1, 2026 | Derek J Maetzold KEY 10b5-1 | Sell S | 6.2K | $129.6K |
| Jun 1, 2026 | Derek J Maetzold KEY 10b5-1 | Exercise M | 6.0K | $14.4K |
| Jun 1, 2026 | Derek J Maetzold KEY 10b5-1 | Exercise M | 204 | $488 |
| May 28, 2026 | Tiffany Olson | Grant A | 11.8K | $0 |
| May 28, 2026 | Ellen Goldberg | Grant A | 11.8K | $0 |
| May 28, 2026 | Miles Harrison | Grant A | 11.8K | $0 |
| May 28, 2026 | Rodney Cotton | Grant A | 11.8K | $0 |
| May 28, 2026 | Kim Caple | Grant A | 11.8K | $0 |
| May 28, 2026 | Bradley G Cole | Grant A | 11.8K | $0 |
| May 28, 2026 | Daniel Bradbury | Grant A | 11.8K | $0 |
| May 28, 2026 | Daniel Bradbury KEY | Grant A | 70.0K | $0 |
About CSTL insider trading
This page tracks insider transactions for CASTLE BIOSCIENCES INC (CSTL) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.